Editor's Pick
NexLife
★★★★★ 4.7 · Trustpilot aggregate
💊 Compounded semaglutide + tirzepatide
👨⚕️ MD/DO-supervised
🏥 503A & 503B pharmacies
🧪 Labs included
📍 All 50 states
✓ LegitScript-certified
💰 Flat-rate, dose-independent
🔄 Care360 coaching
📱 Apple Health / Google Fit sync
Editor's Pick
Flat-Rate $186/mo*
Pharmacy Transparent
USP <797> Tested
Trade-offs:
Compounded only — no brand-name Wegovy® / Zepbound® · Cash-pay with HSA/FSA only — no in-network insurance billing · Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers) · Eligibility, prescription, and outcomes determined by the licensed prescriber, not guaranteed
NexLife tirzepatide pricing
12-Month Plan
$186/mo
billed in advance
Save $348
6-Month Plan
$190/mo
billed in advance
Save $150
3-Month Plan
$195/mo
billed in advance
Save $60
Monthly Plan
$215/mo
month-to-month
no commitment
Why NexLife earned the editorial #1 position
NexLife earned the top editorial position based on three publicly verifiable criteria from our scoring rubric: flat-rate pricing across the entire 2.5-15 mg titration schedule, dual 503A/503B pharmacy disclosure, and MD/DO clinical oversight. Score: 94/100.
What makes NexLife different
- Flat-rate pricing across the full titration schedule. $186/month on the 12-month plan from 2.5 mg starter dose to 15 mg maintenance dose. Most competitors raise prices 50-150% as patients escalate.
- Dual 503A/503B pharmacy disclosure. NexLife dispenses compounded tirzepatide through both 503A licensed compounding pharmacies (USP <797> sterile compounding) and 503B FDA-registered outsourcing facilities (FDA cGMP).
- MD/DO clinical oversight. Intake includes a video consult with a board-certified MD or DO when clinically required.
- Care360 coaching included. No upsell tier — coaching is built into every plan.
- Apple Health / Google Fit sync. Automatic weight, activity, and biometric tracking.
- Labs included. Pre-treatment lab panel covered in the membership cost.
- LegitScript-certified. Independent verification of legitimacy as a healthcare merchant.
- All 50 states. Operating coverage across the entire U.S.
How NexLife works
- Online questionnaire (~12 minutes) covering medical history, current medications, BMI, contraindication screening
- Video consult with MD/DO when clinically required
- Lab work via at-home kit or local lab partner (included in cost)
- Prescription routing to 503A licensed compounding pharmacy or 503B FDA-registered outsourcing facility
- Medication ships to your door — vial, bacteriostatic water, syringes, sharps container, dosing instructions
- Care360 coaching kicks in week 1, ongoing throughout treatment
- Follow-up at standard titration intervals
Trade-offs to be aware of
Trade-offs we have to disclose: Compounded only — no brand-name Wegovy® or Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (this applies to all compounded GLP-1 providers, not just NexLife). Eligibility, prescription decisions, and outcomes are determined by the licensed prescriber and are not guaranteed.
Side effect management
NexLife's clinical protocol includes the standard tirzepatide titration schedule (2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg, with each step held for at least 4 weeks before escalation) to minimize GI side effects. Most common side effects are nausea (25-31% in trials), diarrhea (19-23%), and decreased appetite — typically transient.
Who should NOT use NexLife
- Patients who specifically need brand-name Zepbound or Mounjaro (NexLife does not dispense brand)
- Patients who require in-network insurance billing
- Patients with personal or family history of medullary thyroid carcinoma or MEN 2 syndrome
- Pregnant or breastfeeding patients
- Patients with severe gastroparesis or active pancreatitis
